Login

Interview with Xspray Pharma - Per Andersson, CEO at Xspray Pharma 00:00:00

Share On Facebook Share On Twitter

Interview with Xspray Pharma - Per Andersson, CEO at Xspray Pharma

Recent Videos

00:17:08
Urasar is 100% Hayasa Metals Inc. owned; our exploration license over the Urasar mineral district
00:10:00
Dryden Gold Secures $20M+ War Chest, Delivers High-Grade Discoveries and Expands Drill Targets Across Gold Rock District|Trey Wasser,CEO & Director,Dryden Gold 1
00:10:00
Mitchell Services Targets $50–60M EBITDA as Rig Utilization Drives Earnings Upside| Andrew Elf,CEO,Mitchell Services Limited
00:10:00
Lomiko Metals Reports Strong Pre-Feasibility Results with $800M NPV, Advancing High-Growth Graphite Projects|Gordana Slepcev,CEO,Lomiko Metals Inc.4
00:10:00
Generative AI Meets Wet Lab: Absci Accelerates Biologic Development with Hybrid Business Model|Sean McClain,CEO,Absci
00:10:00
Obliva Aims to Transform Lives of Children with Rare Mitochondrial Disorders|Ellen K. Donnelly ,CEO,Abliva AB7
00:10:00
Abionic Repositions Bio-HDL Therapy CCR001 for Rare Kidney and Eye Disorders with Promising Early Results|Cyrille Tupin,CEO,ABIONYX Pharma
00:10:00
Abingdon Health Reports 45% H1 Revenue Growth Amid Strategic Expansion and Large Contract Wins|Dr Chris Hand,Chairman,Abingdon Health
00:10:00
EB-101 Gene Therapy Shows Promising Results in Treating Recessive Dystrophic EB|Vishwas Seshadri,CEO,Abeona Therapeutics
00:10:00
Revolutionizing Trauma Care: How AAP’s Silver Technology is Fighting Deadly Implant Infections|Rubino Di Girolamo,CEO,aap Implantate AG
00:10:00
Revolutionizing Cancer Treatment: Tumor-Agnostic mTOR Targeting Shows Breakthrough Success in Rare and Genetic-Driven Tumors| Neil Desai, Founder, Executive Chairman ,Aadi Bioscience
00:10:00
Millions Affected, No Approved Cure: 89bio Advances New Therapy for NASH|Rohan Palekar,CEO,89bio Inc2
00:10:00
Malaria Prevention Drug Arakoda Positioned to Drive Future Growth for 60 Degrees Pharmaceuticals|Geoffrey Dow,President,60 Degrees Pharmaceuticals
00:10:00
4DMedical Revolutionizes Lung Imaging with CTVQ: Turning a Simple CT Scan into Functional Lung Diagnostics|Dr Andreas Fouras,CEO,4Dmedical Ltd
00:10:00
4DMedical Revolutionizes Lung Imaging with CTVQ: Turning a Simple CT Scan into Functional Lung Diagnostics|Dr Andreas Fouras,CEO,4Dmedical Ltd
00:10:00
4basebio CEO Heikki Lanckriet Unveils Vision for Next-Generation Synthetic DNA and Gene Therapy Components|Heikki Lanckriet,CEO,4basebio

Suggestions

00:10:00
Stephen Schwarzman Discusses Real Estate Opportunities, U.S.-China Relations, and Presidential Politics | Stephen A. Schwarzman, CEO , The Blackstone Group Inc.
00:10:00
Resolving Muslim Cemetery Dispute in Virginia | Charlie Milbank - Founder of Milbank LLP
00:10:00
Upper 90 invests across stages on companies with predictable revenue models|William Geist,Managing Partner,Upper90
00:10:00
Helps earlystage founders with the capital and tools they need|Ben Lerer,Managing Partner,Lerer Hippeau
00:10:00
Final Tips for Effective Online Training Sessions
00:00:00
Allergy Therapeutics to sniff out more M&A deals - Manuel Llobert, CEO, Allergy Therapeutics
00:10:00
Raising Capital for Early Stage Startups|Marlon Nichols,Managing General Partner,MaC Venture Capital
00:10:00
Rio 2 Limited: Phoenix Gold Project - Largest Undeveloped Gold Heap Leach Project in the Americas
00:10:00
Bogdan Badea of Hidroelectrica Shares Insights on the CHE Bretea Hydropower Project | Bogdan Badea ,CEO , Hidroelectrica SA.
00:10:00
Exploring Private Credit Opportunities: Insights from Drew McKnight of Fortress on Off The Tape with Dan, Guy, and Kaitlin Malin
00:10:00
Political Shifts and Market Reactions: A Conversation with Clarity Capital's CIO | Eran Peleg , the CIO, Israel Clarity Capital.
00:10:00
Charles Kesler on Obama and the Evolution of American Liberalism|Charles Thomas Kessler

© 2026 Nehu